These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 7032111

  • 1. [Guidelines for the evaluation of the therapeutic effects of peripheral vasoactive drugs in arterial occlusive disease].
    Adank K, Barras JP, Biland L, Bollinger A, Galeazzi R, Kämpf R, Mirimanoff P, Schelling JL, Widmer LK.
    Vasa; 1981; 10(4):337-41. PubMed ID: 7032111
    [No Abstract] [Full Text] [Related]

  • 2. [Drug therapy of peripheral arterial occlusive disease].
    Mahler F.
    Schweiz Med Wochenschr; 1981 May 02; 111(18):637-40. PubMed ID: 7244587
    [Abstract] [Full Text] [Related]

  • 3. [Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease].
    Scheffler A, Rieger H.
    Z Arztl Fortbild Qualitatssich; 1999 Nov 02; 93(9):639-44. PubMed ID: 10666827
    [Abstract] [Full Text] [Related]

  • 4. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May 23; 144(21):54. PubMed ID: 12134429
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical trial of a new vasoactive drug F.I. 6714 administered intra-arterially in peripheral vascular diseases].
    Masini G.
    Minerva Cardioangiol; 1975 Feb 23; 23(2):120-5. PubMed ID: 1095956
    [No Abstract] [Full Text] [Related]

  • 6. [Peripheral blood flow velocity in arterial occlusive disease during i.v. long term therapy with vasoactive agents. Plethysmographic comparative study].
    Heidrich H, Witt D, Witt E.
    Verh Dtsch Ges Inn Med; 1975 Feb 23; 83():1750-2. PubMed ID: 347800
    [No Abstract] [Full Text] [Related]

  • 7. [Methods for studying vasoactive drugs in arteriopathy of the leg and chronic venous insufficiency].
    Franco A, Carpentier P.
    Arch Mal Coeur Vaiss; 1990 Mar 23; 83 Spec No 2():79-82. PubMed ID: 2111691
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Peripheral Arterial Occlusive Disease. Modern Therapeutic Principles (author's transl)].
    Hach W, Hach V.
    MMW Munch Med Wochenschr; 1982 Mar 12; 124(10):234-8. PubMed ID: 6806610
    [No Abstract] [Full Text] [Related]

  • 10. [Prostaglandins including prostacyclin in the treatment of peripheral arterial occlusive disorders].
    Alexander K.
    Internist (Berl); 1989 Jul 12; 30(7):429-39. PubMed ID: 2670810
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Buflomedil in arterial occlusive disease. Results of a controlled study].
    Trübestein G, Balzer K, Bisler H, Klüken N, Mahfoud Y, Müller-Wiefel H, Unkel B, Ziegler W.
    Dtsch Med Wochenschr; 1982 Dec 24; 107(51-52):1957-61. PubMed ID: 6756854
    [No Abstract] [Full Text] [Related]

  • 15. [Design and method of clinical trials of drugs used in the therapy of stable peripheral arterial occlusive disease].
    Wink K.
    Arzneimittelforschung; 2006 Dec 24; 56(1):52-7. PubMed ID: 16478006
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Evaluation of the combined use of Nico-padutin forte and depot-Padutin in peripheral arterial occlusive disease].
    Hoffmann J.
    Med Welt; 1982 Jul 16; 33(28):1034-7. PubMed ID: 6922390
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Therapeutic possibilities in peripheral chronic arterial occlusive disease].
    Raithel D.
    Z Allgemeinmed; 1973 Jun 30; 49(18):876-80. PubMed ID: 4728549
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.